Package | Version | Identity | Name/Title | Status | FMM | WG | Date |
---|
hl7.fhir.us.davinci-pdex-plan-net | R4 | ValueSet/IndividualSpecialtyAndDegreeLicenseCertificateVS | Individual Specialties, Degrees, Licenses, and Certificates VS | trial-use | | fm | 2025-02 |
hl7.fhir.us.ndh | R4 | ValueSet/IndividualSpecialtyAndDegreeLicenseCertificateVS | Individual Specialties, Degrees, Licenses, and Certificates Value Set | trial-use | | pa | 2025-07 |
hl7.fhir.us.directory-query | R4 | ValueSet/IndividualAndGroupSpecialtiesVS | Individual and Group Specialties | active | | | 2022-12 |
hl7.fhir.us.davinci-pdex-plan-net | R4 | ValueSet/IndividualAndGroupSpecialtiesVS | Individual and Group Specialties | trial-use | | fm | 2025-02 |
hl7.fhir.us.ndh | R4 | ValueSet/IndividualAndGroupSpecialtiesVS | Individual and Group Specialties | trial-use | | pa | 2025-07 |
fhir.cdc.opioid-cds-r4 | R4 | ValueSet/non-opioid-urine-drug-screening | Non-opioid drug urine screening | active | | | 2023-05 |
fhir.cdc.opioid-cds-r4 | R4 | ValueSet/opioid-urine-drug-screening | Opioid drug urine screening | active | | | 2023-05 |
fhir.cdc.opioid-cds-r4 | R4 | ValueSet/xylazine-urine-drug-screening-tests | Xylazine drug urine screening tests | active | | | 2024-05 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1095.2 | Food and Nutrient Delivery SNOMED CT | active | | | 2025-05 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.227 | Findings Related to Medication Management, Infectious Disease Symptoms | active | | | 2021-03 |
signal.core.r4 | R4 | ValueSet/questionnaire-ccars-current-living-arrangement | Questionnaire CCARS Current Living Arrangement | draft | 1 | pa | |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1010.7 | Clinical Drug Ingredient | active | | | 2024-06 |
hl7.fhir.us.pacio-adi | R4 | ValueSet/ADIInitialTreatmentPMOOptionsVS | Initial Treatment Portable Medical Order Options | trial-use | 2 | pe | 2025-08 |
fhir.virtually.healthcare | R4 | ValueSet/BARSReferralCode | BARS Referral Code | draft | | | 2025-08 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1032.308 | Cardiovascular disease 10Y risk | active | | | 2024-02 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1021.41 | MDP Test HL7 Intensional | active | | | 2019-01 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1032.266 | Rhabdomyolysis Intensional | active | | | 2024-06 |
hl7.fhir.us.vrdr | R4 | ValueSet/vrdr-intentional-reject-vs | Intentional Reject ValueSet | active | | pher | 2024-10 |
hl7.fhir.us.mcode | R4 | ValueSet/mcode-rhabdomyosarcoma-clinical-group-value-vs | Rhabdomyosarcoma Clinical Group Value | active | | cic | 2025-02 |
hl7.fhir.us.breastcancer | R3 | ValueSet/shr-core-PositiveNegativeEquivocalIndeterminateVS | BC PositiveNegativeEquivocalIndeterminateVS ValueSet | draft | | | 2018-08 |
hl7.fhir.us.breastcancer | R3 | ValueSet/oncology-RecurrenceRiskScoreInterpretationVS | BC RecurrenceRiskScoreInterpretationVS ValueSet | draft | | | 2018-08 |
hl7.fhir.us.registry-protocols | R4 | ValueSet/InterventionTypes | Intervention Types | active | | cic | 2023-11 |
fhir.org.nz.ig.base | R4 | ValueSet/nz-residency | NZ Residency status | active | | | 2025-06 |
hl7.fhir.us.codex-radiation-therapy | R4 | ValueSet/codexrt-radiotherapy-isotope-vs | Radiotherapy Isotope Value Set | active | | cgp | 2025-02 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1221.189 | Infertility, Male | active | | | 2024-04 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1221.190 | Infertility, Male | active | | | 2024-04 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1221.191 | Infertility, Male | active | | | 2024-04 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1222.1446 | Covid Toes (Toes and/or Fingers) | active | | | 2024-06 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1078.193 | relatedconditions_COPD I10 | active | | | 2023-03 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1078.173 | Asthma I10 | active | | | 2025-05 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1032.102 | Suicide Attempt | active | | | 2024-06 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1248.94 | Oxygen Partial Pressure in Arterial Blood | active | | | 2024-01 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1248.95 | Carbon Dioxide Partial Pressure in Arterial Blood | active | | | 2024-01 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1248.96 | Arterial Blood pH | active | | | 2024-01 |
fhir.outburn.co.il | R4 | ValueSet/vs-pregnancy-hospitalization-type | Pregnancy Hospitalization Type codes | draft | | | |
fhir.outburn.co.il | R4 | ValueSet/vs-pregnancy-outcome | Pregnancy Outcome codes | draft | | | |
hl7.fhir.us.ccda | R4 | ValueSet/1.3.6.1.4.1.12009.10.2.5 | LOINC Imaging Document Codes | trial-use | | cgp | 2022-07 |
hl7.fhir.us.ccda | R4 | ValueSet/2.16.840.1.113883.11.20.6.1 | ProcedureNoteDocumentTypeCodes | trial-use | | cgp | 2018-05 |
hl7.fhir.us.ccda | R4 | ValueSet/2.16.840.1.113883.11.20.8.1 | ProgressNoteDocumentTypeCode | trial-use | | cgp | 2018-05 |
hl7.fhir.us.pacio-adi | R4 | ValueSet/LOINCPOLSTCPRAnswerList | LOINC POLST CPR Answer List | trial-use | 2 | pe | 2025-08 |
hl7.fhir.us.pacio-adi | R4 | ValueSet/LOINCPOLSTInitialTxAnswerList | LOINC POLST Initial Tx Answer List | trial-use | 2 | pe | 2025-08 |
hl7.fhir.us.pacio-adi | R4 | ValueSet/LOINCPOLSTMedAssistNutrAnswerList | LOINC POLST Med assist nutr Answer List | trial-use | 2 | pe | 2025-08 |
hl7.fhir.us.pacio-adi | R4 | ValueSet/LOINCPOLSTDiscussPartAnswerList | LOINC POLST discuss part List | trial-use | 2 | pe | 2025-08 |
hl7.fhir.us.pacio-adi | R4 | ValueSet/LOINCPOLSTReviewAnswerList | LOINC POLST review Answer List | trial-use | 2 | pe | 2025-08 |
hl7.fhir.us.registry-protocols | R4 | ValueSet/RoseDyspneaQ | Rose Dyspnea Questions | active | | cic | 2023-11 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1078.202 | Serum Creatinine | active | | | 2024-02 |
hl7.fhir.us.registry-protocols | R4 | ValueSet/SeattleAnginaAs | Seattle Angina Answers | active | | cic | 2023-11 |
hl7.fhir.us.davinci-pas | R4 | ValueSet/X12278DiagnosisInformationType | X12 278 Diagnosis Information Type | trial-use | 3 | fm | 2025-07 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.635 | LP(a) Test_ICD | active | | | 2025-03 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1260.50 | MSI High | active | | | 2023-11 |
hl7.fhir.us.core | R4 | ValueSet/us-core-laboratory-test-codes | US Core Laboratory Test Codes | trial-use | 3 | cgp | 2022-11 |
fhir.cdc.opioid-cds-r4 | R4 | ValueSet/observation-category-laboratory | Observation Category Laboratory | active | | | 2023-05 |
hl7.fhir.us.breastcancer | R3 | ValueSet/oncology-HER2byFISHVSInterpretationTestsVS | BC HER2byFISHVSInterpretationTestsVS ValueSet | draft | | | 2018-08 |
hl7.fhir.us.breastcancer | R3 | ValueSet/oncology-EstrogenReceptorInterpretationTestsVS | BC EstrogenReceptorInterpretationTestsVS ValueSet | draft | | | 2018-08 |
hl7.fhir.us.breastcancer | R3 | ValueSet/oncology-HER2byIHCInterpretationTestsVS | BC HER2byIHCInterpretationTestsVS ValueSet | draft | | | 2018-08 |
hl7.fhir.us.breastcancer | R3 | ValueSet/oncology-ProgesteroneReceptorInterpretationTestsVS | BC ProgesteroneReceptorInterpretationTestsVS ValueSet | draft | | | 2018-08 |
signal.core.r4 | R4 | ValueSet/questionnaire-ccars-legal-status | Questionnaire CCARS Legal Status | draft | 1 | pa | |
hl7.fhir.us.registry-protocols | R4 | ValueSet/LesionSegmentNumber | Lesion Segment Number | active | | cic | 2023-11 |
hl7.fhir.us.mcode | R4 | ValueSet/mcode-clark-level-value-vs | Clark Level Value Set | active | | cic | 2025-02 |
signal.core.r4 | R4 | ValueSet/questionnaire-answers-status | QuestionnaireResponseStatus | draft | 3 | fhir | 2019-10 |
hl7.fhir.us.mcode | R4 | ValueSet/mcode-tnm-distant-metastases-staging-type-max-vs | TNM Distant Metastases Staging Type Maximum Value Set | active | 4 | cic | 2025-02 |
hl7.fhir.us.mcode | R4 | ValueSet/mcode-tnm-primary-tumor-staging-type-max-vs | TNM Primary Tumor Staging Type Maximum Value Set | active | 4 | cic | 2025-02 |
hl7.fhir.us.mcode | R4 | ValueSet/mcode-tnm-regional-nodes-staging-type-max-vs | TNM Regional Nodes Staging Type Maximum Value Set | active | 4 | cic | 2025-02 |
hl7.fhir.us.mcode | R4 | ValueSet/mcode-tnm-stage-group-staging-type-max-vs | TNM Stage Group Staging Type Maximum Value Set | active | 4 | cic | 2025-02 |
hl7.fhir.us.mcode | R4 | ValueSet/mcode-condition-status-trend-max-vs | Condition Status Trend Maximum Value Set | active | 3 | cic | 2025-02 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.636 | Lp(a) Test_CPT | active | | | 2025-03 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.637 | LP(a) Test | active | | | 2025-03 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.634 | Lp(a) Test_LOINC | active | | | 2025-03 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.633 | Lp(a) Test_SNOMED | active | | | 2025-03 |
hl7.fhir.us.resp-net | R4 | ValueSet/resp-net-labtest-covid-codes | resp-net-labtest-covid-codes | draft | | | 2025-08 |
hl7.fhir.us.resp-net | R4 | ValueSet/resp-net-labtest-flu-codes | resp-net-labtest-flu-codes | draft | | | 2025-08 |
hl7.fhir.us.resp-net | R4 | ValueSet/resp-net-labtest-flu-rsv-covid-codes | resp-net-labtest-flu-rsv-covid-codes | draft | | | 2025-08 |
hl7.fhir.us.resp-net | R4 | ValueSet/resp-net-labtest-rsv-codes | resp-net-labtest-rsv-codes | draft | | | 2025-08 |
hl7.fhir.us.davinci-crd | R4 | ValueSet/cardType | CRD Card Types Value Set | trial-use | 4 | fm | 2025-08 |
hl7.fhir.us.resp-net | R4 | ValueSet/resp-net-positive-result-codes | resp-net-positive-result-codes | draft | | | 2025-08 |
hl7.fhir.us.resp-net | R4 | ValueSet/resp-net-negative-result-codes | resp-net-negative-result-codes | draft | | | 2025-08 |
hl7.fhir.us.davinci-crd | R4 | ValueSet/DocReason | CRD Coverage Information Documentation Reason Value Set | trial-use | 1 | fm | 2025-08 |
rapportendoscopiequebec.test | R4 | ValueSet/ca-qc-endo-valueset-villeendo | VilleEndo | active | | | 2024-05 |
rapportendoscopiequebec.test | R4 | ValueSet/ca-qc-endo-valueset-voieadministrationendo | VoieAdministrationEndo | active | | | 2024-05 |
hl7.fhir.us.registry-protocols | R4 | ValueSet/Antiarrhythmics | All Antiarrhythmics | active | | cic | 2023-11 |
hl7.fhir.us.pq-cmc-fda | R5 | ValueSet/cmc-specification-types-vs | Specification Section Type Terminology | trial-use | 2 | brr | 2025-07 |
ca.on.dhdr.r4.v4 | R4 | ValueSet/accdr-vs-location-physical-type | Location Physical Type | active | | | |
hl7.fhir.us.registry-protocols | R4 | ValueSet/LocationInGraft | Location in the CABG Graft | active | | cic | 2023-11 |
hl7.fhir.us.registry-protocols | R4 | ValueSet/ValvularStenosis | Valvular Stenosis | active | | cic | 2023-11 |
hl7.fhir.us.breast-radiology | R4 | ValueSet/LymphNodeAbnormalityTypeVS | Lymph Node Type ValueSet | active | | | 2022-12 |
hl7.fhir.us.registry-protocols | R4 | ValueSet/CABGType | Coronary Artery Bypass Graft Type | active | | cic | 2023-11 |
hl7.fhir.us.registry-protocols | R4 | ValueSet/StentType | CathPCI List of Stent Types | active | | cic | 2023-11 |
fhir.mamaToto | R4 | ValueSet/maritalStatusVS | Marital Status | draft | | | 2025-06 |
fhir.r4.wales.test | R4 | ValueSet/DataStandardsWales-MaritalStatus | Data Standards Wales Marital Status | active | | | 2023-08 |
signal.core.r4 | R4 | ValueSet/questionnaire-ccars-marital-status | Questionnaire CCARS Marital Status | draft | 1 | pa | |
hl7.fhir.us.spl | R5 | ValueSet/valueset-splMarketingStatuses | SPL Marketing Statuses ValueSet | trial-use | 1 | brr | 2025-07 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1138.564 | CABG or PCI Procedure | active | | | 2025-02 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1138.565 | CABG or PCI Procedure | active | | | 2025-01 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1138.566 | CABG or PCI Procedure | active | | | 2018-08 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.464.1003.120.11.1007 | HIV 1 | active | | | 2024-11 |
hl7.fhir.us.davinci-vbpr | R4 | ValueSet/vbp-measure-population | VBP Measure Population Type | trial-use | 1 | cqi | 2025-07 |
hl7.fhir.us.registry-protocols | R4 | ValueSet/MechanicalVentricularSupportTiming | Mechanical Ventricular Support Timing | active | | cic | 2023-11 |
hl7.fhir.us.icsr-ae-reporting | R4 | ValueSet/MedDRATransfusionAdverseEventVS | Transfusion-related Adverse Events | draft | | | 2023-08 |
hl7.fhir.us.icsr-ae-reporting | R4 | ValueSet/MedDRAVaccinationAdverseEventVS | Vaccination-related Adverse Events | draft | | | 2023-08 |
signal.core.r4 | R4 | ValueSet/questionnaire-ccars-rae-aso-identification-codes | Questionnaire CCARS RAE ASO Identification Codes | draft | 1 | pa | |
hl7.fhir.us.pacio-adi | R4 | ValueSet/ADIDMedicallyAssistedHydrationNutritionOrderGroupingVS | Medically Assisted Hydration Order Grouping | trial-use | 2 | pe | 2025-08 |
hl7.fhir.us.pacio-adi | R4 | ValueSet/ADIDMedicallyAssistedHydrationNutritionOrderVS | Medically Assisted Hydration Order | trial-use | 2 | pe | 2025-08 |
fhir.cdc.opioid-cds-r4 | R4 | ValueSet/methadone-medications | Methadone medications | active | | | 2025-02 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.183 | Findings Related to Medication Management, Medication related | active | | | 2021-03 |
fhir.cdc.opioid-cds-r4 | R4 | ValueSet/cns-depressant-medications | CNS depressant medications | active | | | 2025-02 |
fhir.cdc.opioid-cds-r4 | R4 | ValueSet/non-synthetic-opioid-medications | Non-synthetic opioid medications | active | | | 2025-02 |
signal.core.r4 | R4 | ValueSet/questionnaire-ccars-history-of-mental-health-services | Questionnaire CCARS History Of Mental Health Services | draft | 1 | pa | |
hl7.fhir.us.dme-orders | R4 | ValueSet/PAOx-Message-Event | PAO Message Event | draft | | | 2023-06 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.15 | MetabolicSyndromeCondition | active | | | 2025-01 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.9 | Metabolic Syndrome ICD10 | active | | | 2025-03 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.12 | Metabolic Syndrome LOINC | active | | | 2025-02 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1260.33 | Metastatic Breast Cancer | active | | | 2023-09 |
hl7.fhir.us.codex-radiation-therapy | R4 | ValueSet/codexrt-radiotherapy-respiratory-motion-management-vs | Radiotherapy Respiratory Motion Management Value Set | active | | cgp | 2025-02 |
hl7.cda.us.eyecare | R5 | ValueSet/RefractionMethodCodes | Refraction Method Codes | draft | | | 2024-02 |
hl7.cda.us.eyecare | R5 | ValueSet/VisualAcuityMethodCodes | Visual Acuity Method Codes | draft | | | 2024-02 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1260.49 | MSI Testing | active | | | 2023-11 |
hl7.fhir.us.military-service | R4 | ValueSet/military-service-branch-vs | Military Branch Value Set | active | | | 2023-05 |
hl7.fhir.us.military-service | R4 | ValueSet/military-service-military-occupation-vs | Military Occupation Value Set | active | | | 2023-05 |
hl7.fhir.us.directory-query | R4 | ValueSet/MinEndpointConnectionTypeVS | Minimum Endpoint Connection Types Value Set | active | | | 2022-12 |
hl7.fhir.us.davinci-pdex-plan-net | R4 | ValueSet/MinEndpointConnectionTypeVS | Minimum Endpoint Connection Types VS | trial-use | | fm | 2025-02 |
hl7.fhir.us.codex-radiation-therapy | R4 | ValueSet/codexrt-image-guided-radiotherapy-modality-vs | Image Guided Radiotherapy Modality Value Set | active | | cgp | 2025-02 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1078.112 | Chronic kidney disease I10 | active | | | 2023-09 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1260.28 | Her2 Negative | active | | | 2023-09 |
fhir.org.nz.ig.base | R4 | ValueSet/nhi-use | Valid use values for NHI | active | | | 2025-06 |
fhir.r4.nhsengland.programme | R4 | ValueSet/England-ObservationCode | England Observation Code | draft | | | 2024-12 |
fhir.r4.nhsengland.programme | R4 | ValueSet/England-ObservationValueCode | England Observation Value Code | draft | | | 2024-12 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1190.89 | Maternal Diagnoses | active | | | 2023-10 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1032.55 | Risk assessments relevant to pain management | active | | | 2024-06 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1108.180 | Outpatient Prenatal Visit | active | | | 2024-09 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1108.182 | Eclampsia | active | | | 2024-10 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1108.184 | Preexisting Hypertension in Pregnancy | active | | | 2024-10 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1108.185 | Postpartum Encounter | active | | | 2024-10 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1108.186 | Postpartum Encounter | active | | | 2024-10 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1108.187 | Postpartum Encounter | active | | | 2024-10 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1108.189 | Spontaneous or Elective Abortion | active | | | 2024-10 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1108.190 | Spontaneous or Elective Abortion | active | | | 2024-10 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1108.191 | Preeclampsia or Eclampsia | active | | | 2024-10 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1108.193 | Spontaneous or Elective Abortion | active | | | 2024-10 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1108.179 | Hypertensive disorders in pregnancy | active | | | 2024-10 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1108.192 | Spontaneous or Elective Abortion Procedure | active | | | 2025-01 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1108.183 | Gestational Hypertension | active | | | 2024-10 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1108.188 | Preexisting Hypertension in Pregnancy | active | | | 2024-10 |
hl7.fhir.us.davinci-pct | R4 | ValueSet/PCTGFEItemRevenueVS | PCT GFE NUBC Revenue Value Set | trial-use | | fm | 2025-08 |
hl7.fhir.us.davinci-pct | R4 | ValueSet/PCTGFETypeOfBillVS | PCT GFE NUBC Uniform Billing (UB-04) Type of Bill Value Set | trial-use | | fm | 2025-08 |
signal.core.r4 | R4 | ValueSet/provider-taxonomy | Provider Taxonomy Codes | draft | | vocab | 2023-03 |
fhir.cdc.opioid-cds-r4 | R4 | ValueSet/oncology-specialty-designations | Oncology specialty designations (NUCC) | active | | | 2023-05 |
hl7.fhir.us.vdor | R4 | ValueSet/vdor-gun-owner-codes-vs | VDOR Coding Manual Gun Owner Codes Value Set | informative | | pher | 2025-06 |
hl7.fhir.us.registry-protocols | R4 | ValueSet/NewYorkHeartAssociationAnswers | New York Heart Association OA Answer List | active | | cic | 2023-11 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1021.121 | Federal Administrative Sex | active | | | 2025-02 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1032.292 | Non pharmacologic treatments for chronic pain NCI | active | | | 2024-06 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1078.581 | PIM_Avandamet | active | | | 2023-08 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1032.26 | Nonopioid pain medications | active | | | 2023-03 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.11.20.9.59 | DIRSectionTypeCodes | active | | | 2024-06 |
fhir.org.nz.ig.base | R4 | ValueSet/coverage-type | Coverage Type | active | | | 2025-06 |
fhir.org.nz.ig.base | R4 | ValueSet/coverage-category | Coverage Category | active | | | 2025-06 |
fhir.org.nz.ig.base | R4 | ValueSet/iwi | Iwi | active | | | 2025-06 |
fhir.giis | R4 | ValueSet/NonVaccinationReasonVS | Non vaccination reason | draft | | | 2025-07 |
hl7.fhir.us.hsds | R4 | ValueSet/NonIndividualSpecialties | Non-Individual Specialties | trial-use | 2 | hss | 2023-10 |
hl7.fhir.us.directory-query | R4 | ValueSet/NonIndividualSpecialtiesVS | Non-Individual Specialties | active | | | 2022-12 |
hl7.fhir.us.davinci-pdex-plan-net | R4 | ValueSet/NonIndividualSpecialtiesVS | Non-Individual Specialties | trial-use | | fm | 2025-02 |
hl7.fhir.us.directory-query | R4 | ValueSet/NonIndividualSpecialtyAndDegreeLicenseCertificateVS | Non-Individual Specialties, Degrees, Licenses, and Certificates Value Set | active | | | 2022-12 |
hl7.fhir.us.davinci-pdex-plan-net | R4 | ValueSet/NonIndividualSpecialtyAndDegreeLicenseCertificateVS | Non-Individual Specialties, Degrees, Licenses, and Certificates VS | trial-use | | fm | 2025-02 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1046.279 | Triage | active | | | 2025-02 |
hl7.fhir.us.registry-protocols | R4 | ValueSet/NonSustainedVentricularTachycardiaType | Non-Sustained Ventricular Tachycardia Type | active | | cic | 2023-11 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1213.114 | NSAIDs Ingredients and Risk of GI Bleeding | active | | | 2023-12 |
hl7.fhir.us.mcode | R4 | ValueSet/mcode-normalization-basis-vs | Normalization Basis Value Set | active | | cic | 2025-02 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1247.208 | Social Determinants of Health Screening Assessments Answers | active | | | 2024-12 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1247.207 | Social Determinants of Health Screening Assessments Questions | active | | | 2024-12 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1247.206 | Social Determinants of Health Screening Assessments And Questions | active | | | 2024-12 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1247.126 | Social Determinants of Health Screening Assessments | active | | | 2023-12 |
hl7.fhir.us.breast-radiology | R4 | ValueSet/NotPreviouslySeenVS | NotPreviouslySeen ValueSet | active | | | 2022-12 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1222.815 | Drugs of Abuse Screen in Urine | active | | | 2023-07 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1222.898 | Forearm X Ray | active | | | 2024-07 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1078.455 | Metabolic acidosis I10 | active | | | 2023-07 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1115.15 | Upon Death Preferences | active | | | 2025-04 |
hl7.fhir.us.davinci-crd | R4 | ValueSet/cmslocationcodes | CMS Location Codes Value Set | trial-use | 4 | fm | 2025-08 |
us.nlm.vsac | R4 | ValueSet/1.3.6.1.4.1.6997.4.1.2.234.13.13.1.15.1.999.1 | Selected non pharmaceutical therapies for moderate to severe chronic pain | active | | | 2015-08 |
us.nlm.vsac | R4 | ValueSet/1.3.6.1.4.1.6997.4.1.2.234.13.13.1.16.1.11.1.999.3 | selected muscle relaxants for pain control | active | | | 2015-08 |
us.nlm.vsac | R4 | ValueSet/1.3.6.1.4.1.6997.4.1.2.234.13.13.1.16.1.12.1.999.3 | Selected topical agents for pain control | active | | | 2015-08 |
us.nlm.vsac | R4 | ValueSet/1.3.6.1.4.1.6997.4.1.2.234.13.13.1.17.1.1.999.2 | selected non opioids for moderate to severe pain | active | | | 2015-08 |
us.nlm.vsac | R4 | ValueSet/1.3.6.1.4.1.6997.4.1.2.234.13.13.1.17.1.11.1.999.2 | Selected opioids for moderate to severe pain | active | | | 2015-08 |
us.nlm.vsac | R4 | ValueSet/1.3.6.1.4.1.6997.4.1.2.234.15.2.1.1.999.1 | Selected urine drug screens for opioids indicating testing is complete | active | | | 2015-08 |
us.nlm.vsac | R4 | ValueSet/1.3.6.1.4.1.6997.4.1.2.234.999.2 | Selected urine screening for patients receiving opioid therapy | active | | | 2015-08 |
us.nlm.vsac | R4 | ValueSet/1.3.6.1.4.1.6997.4.1.2.234.999.3.1 | Opioids used for pain control | active | | | 2015-08 |
us.nlm.vsac | R4 | ValueSet/1.3.6.1.4.1.6997.4.1.2.234.13.13.1.16.1.1.999.3 | selected first line medications for pain control | active | | | 2015-08 |
us.nlm.vsac | R4 | ValueSet/1.3.6.1.4.1.6997.4.1.2.234.15.7.1.1.11.1.999.1 | selected follow up visit intervals for opioid monitoring | active | | | 2015-08 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.3157.1019 | Diseases of Urinary System | active | | | 2020-07 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.3157.1301 | Surgery Integumentary System Breast | active | | | 2020-07 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.3157.1302 | Surgery Respiratory System Accessory Sinuses | active | | | 2020-07 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.3157.1303 | Surgery Respiratory System Larynx | active | | | 2020-07 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.3157.1304 | Surgery Respiratory System Trachea and Bronchi | active | | | 2020-07 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.3157.1305 | Surgery Respiratory System Lungs and Pleura | active | | | 2020-07 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.3157.13064 | Surgery Digestive System Esophagus | active | | | 2020-06 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.3157.1307 | Surgery Digestive System Intestines (Except Rectum) | active | | | 2017-05 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.3157.1308 | Surgery Digestive System Rectum | active | | | 2019-08 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.3157.1309 | Surgery Digestive System Anus | active | | | 2020-07 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.3157.1310 | Surgery Digestive System Biliary Tract | active | | | 2020-07 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.3157.1311 | Surgery Digestive System Abdomen Peritoneum Omentum | active | | | 2020-07 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.3157.1312 | Surgery Digestive System Kidney | active | | | 2020-07 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.3157.13133 | Surgery Digestive System Ureter | active | | | 2017-05 |